Barry J. Hoffer
Affiliations: | National Institute on Drug Abuse |
Area:
PharmacologyWebsite:
http://www.drugabuse.gov/DIR/cell-neuro.htmlGoogle:
"Barry Hoffer"Mean distance: 12.89 (cluster 6) | S | N | B | C | P |
Cross-listing: Neurotree
Parents
Sign in to add mentor| Lowell Winship Lapham | post-doc | 1967-1968 | Rochester (Neurotree) |
| Floyd E. Bloom | post-doc | 1968-1970 | NIMH (Neurotree) |
Children
Sign in to add trainee| Jaime M. Ross | grad student | 2006-2012 | Karolinska Institutet - NIDA (Neurotree) |
| Cristina Backman | post-doc | NIDA (Neurotree) | |
| Paula C. Bickford | post-doc | CU Boulder (Neurotree) | |
| Tom Dunwiddie | post-doc | CU Boulder | |
| Greg Gerhardt | post-doc | NIDA (Neurotree) | |
| Ann-Charlotte Granholm | post-doc | CU Boulder (Neurotree) | |
| Brandon K. Harvey | post-doc | NIDA (Neurotree) | |
| Ingrid Stromberg | post-doc | CU Boulder (Neurotree) | |
| David A. Taylor | post-doc | 1974-1977 | CU Boulder (Neurotree) |
Collaborators
Sign in to add collaborator| Lars Olson | collaborator | Center for Hearing and Communication, Karolinska Institutet, Sweden (Neurotree) | |
| Richard Jay Smeyne | collaborator | 2012- | Case Western Medical School (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang V, Tseng KY, Kuo TT, et al. (2024) Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice. Journal of Biomedical Science. 31: 38 |
| Glotfelty EJ, Tovar-Y-Romo LB, Hsueh SC, et al. (2023) The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia. Cells. 12 |
| Kuo TT, Chen YH, Wang V, et al. (2023) PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 24 |
| Tseng KY, Kuo TT, Wang V, et al. (2022) Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. Journal of Parkinson's Disease |
| Chen YH, Wu KJ, Hsieh W, et al. (2021) Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein. Genes. 12 |
| Wang V, Kuo TT, Huang EY, et al. (2021) Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. Acs Pharmacology & Translational Science. 4: 858-869 |
| Yu SJ, Chen S, Yang YY, et al. (2020) PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in Neuroscience. 14: 785 |
| Tweedie D, Karnati HK, Mullins R, et al. (2020) Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury. Elife. 9 |
| Lin CT, Lecca D, Yang LY, et al. (2020) 3,6'-Dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation. Elife. 9 |
| Chen YH, Yu SJ, Wu KJ, et al. (2020) Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody. Journal of Parkinson's Disease |